Clinical evidence for hydroxychloroquine and azithromycin combination therapy for COVID-19

This item is OpenAccessThis item is covered by a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 Internationa. Click to find out more
Share this page with addthis.com
Thumbnail
File Type:
PDF
Item Type:
report
Date:
2020-04-02
Author:
National Centre for Pharmacoeconomics (NCPE Ireland)
Medicines Management Programme (MMP)
National Medicines Information Centre (NMIC)
COVID-19 Evidence Review Group for Medicines
Access:
openAccess
Citation:
National Centre for Pharmacoeconomics (NCPE Ireland), Medicines Management Programme (MMP), National Medicines Information Centre (NMIC), COVID-19 Evidence Review Group for Medicines, 'Clinical evidence for hydroxychloroquine and azithromycin combination therapy for COVID-19', [report], 2020-04-02
Download Item:
URI:
http://hdl.handle.net/2262/102606
Corporate name:
National Centre for Pharmacoeconomics (NCPE Ireland)
Medicines Management Programme (MMP)
National Medicines Information Centre (NMIC)
COVID-19 Evidence Review Group for Medicines
Author: National Centre for Pharmacoeconomics (NCPE Ireland); Medicines Management Programme (MMP); National Medicines Information Centre (NMIC); COVID-19 Evidence Review Group for Medicines
Corporate name:
National Centre for Pharmacoeconomics (NCPE Ireland)
Medicines Management Programme (MMP)
National Medicines Information Centre (NMIC)
COVID-19 Evidence Review Group for Medicines
Type of material:
report
URI:
http://hdl.handle.net/2262/102606
Collections
Availability:
Full text available
Subject:
Covid-19, Coronavirus, Hydroxychloroquine, Azithromycin, Combination therapy
Metadata
Show full item record

The following license files are associated with this item: